FREDERICK, Md.--(BUSINESS WIRE)--Akonni Biosystems, a molecular diagnostics company that develops, manufactures and plans to market a fully integrated multiplex system for simultaneously identifying and differentiating hundreds of genetic signatures from a single sample, today announced availability of its TruSentry system for early access customers. This new, fully automated solution is designed for government institutions and large centers seeking to increase their capacity for rapid identification of infectious microorganisms and drug resistant variants at a significantly lower overall cost.
